NCT04360915

Assessing the Pharmacokinetics Effects of Food on ASK120067 in Single Oral Administration in Chinese Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To evaluate the pharmacokinetic characteristics of ASK120067 and CCB4580030 after the single oral administration of ASK120067 in fast and after a high-fat meal in healthy Chinese subjects, and to evaluate the effect of food on the bioavailability of ASK120067.To evaluate the safety of ASK120067 tablets administered orally in fast and fed.

Conditions

• Locally Advanced or Metastatic NSCLC

Interventions

Type	Name	Description
DRUG	ASK120067	Take ASK120067 tablets orally in first day at 160 mg in fast condition.
DIETARY_SUPPLEMENT	ASK120067 in fed condition	Take ASK120067 tablets orally in first day at 160 mg in fed condition.

Timeline

• Start date: 2019-12-09
• Primary completion: 2019-12-30
• Completion: 2019-12-30
• First posted: 2020-04-24
• Last updated: 2020-04-29

Locations

1 site across 1 country: China